hPSCreg®
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details. This website uses cookies, learn more

Search results

Sort by:

Filter by:

  1. AHQUi001-A (IPS35-2)

    China Affiliated Hospital of Qingdao University (AHQU)
    Disease:

    Non rare in europe: hyperlipoproteinemia type 4

  2. ATLABi001-A (AT-MODY3-iP001)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  3. ATLABi002-A (AT-MODY3-iP002)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  4. ATLABi006-A (AT-UC C Normal-iC16)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  5. ATLABi007-A (AT-UC C Normal-iC46)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  6. ATLABi008-A (AT-UC I Normal-iC06)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  7. ATLABi009-A (AT-UC I Normal-iC13)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  8. ATLABi010-A (AT-MODY10-iII1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  9. ATLABi011-A (AT-MODY10-iII4)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  10. ATLABi012-A (AT-M10 Normal-iI2)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  11. ATLABi013-A (AT-M10 Normal-iII3)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  12. ATLABi014-A (AT-MODY10-iI1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  13. BCHNi001-A (BCHi001-A)

    China Beijing Children′s Hospital：Department of Nephrology (BCHN)
    Disease:

    Bardet-biedl syndrome

  14. BCHNCi001-A

    China Beijing Children's Hospital, Center of Neurology (BCHNC)
    Disease:

    Early infantile epileptic encephalopathy

  15. BCMi001-A (M22c5 and HSCC-003iPS-Sc5)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  16. BCMi001-B (M22c8 and HSCC-003iPS-Sc8)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  17. BIOi002-A

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Autosomal dominant optic atrophy

  18. BIOi003-A (LYN-C1-P6)

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Hereditary retinal dystrophy

  19. BJTTHi001-A

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Normal

  20. BRCi021-A (TUH1)

    Japan RIKEN BioResource Research Center (BRC)
    Disease:

    Cardiomyopathy

  21. CHAe001-A (CHA-hES3)

    South Korea Pochon CHA University (CHA)

  22. CIPi001-A

    China Children’s Hospital of Capital Institute of Pediatrics (CIP)
    Disease:

    Benign familial infantile epilepsy

  23. CIRAi006-A (F2KU2#17 and F2KU2)

    Japan Center for iPS Cell Research and Application (CIRA)
    Disease:

    Facioscapulohumeral muscular dystrophy 2

  24. CPGHi004-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal

  25. CPGHi006-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal dominant polycystic kidney disease

  26. CPGHi007-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal

  27. CPGHi008-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal recessive polycystic kidney disease

  28. CSUe004-A (chHES-20)

    China Central South University (CSU)

  29. CSUe005-A (chHES-22)

    China Central South University (CSU)

  30. WAe009-A-10 (EBNA1+H9 and H9-EBNA)

    China Central South University (CSU)
    Disease:

    Normal

  31. DALCe001-A (ReliCellhES1)

    India Dhirubhai Ambani Life Sciences Center (DALC)

  32. DANi006-F (GBA-006-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  33. DANi008-F (SNCA-008-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  34. ESi049-A (MS FiPS 2 R4F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_multiple sclerosis

  35. ESi050-A (MS FiPS 3-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  36. ESi051-A (MS FiPS 4-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_multiple sclerosis

  37. ESi052-A (MS FiPS 5-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  38. ESi053-A (MS FiPS 6-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  39. ESi068-A (SWB FiPS 159-R4F-4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams-beuren syndrome

  40. ESi069-A (SWB FiPS 344-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams-beuren syndrome

  41. ESi070-A (DUPSW FiPS 501-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  42. ESi071-A (DUPSW FiPS 701-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  43. ESi094-A (Hz 1-8-3 CBiPS4 Sv4F F6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal

  44. FDCHDPi001-A (FDCHDP01)

    China Fudan University (FDCHDP)
    Disease:

    Tourette syndrome

  45. FJMUUHi001-A

    China Fujian Medical University Union Hospital (FJMUUH)
    Disease:

    Parkinson's disease 7

  46. GENEAe001-A (GENEA001 and SIVF01)

    Australia Genea (GENEA)
    Disease:

    Normal

  47. GENEAe002-A (GENEA003 and SIVF03)

    Australia Genea (GENEA)

  48. GENEAe003-A (SIVF04 and GENEA004)

    Australia Genea (GENEA)

  49. GENEAe004-A (SIVF05 and GENEA005)

    Australia Genea (GENEA)

  50. GENEAe005-A (SIVF06 and GENEA006)

    Australia Genea (GENEA)

  51. GENEAe006-A (SIVF07 and GENEA007)

    Australia Genea (GENEA)

  52. GENEAe007-A (GENEA008 and SIVF08)

    Australia Genea (GENEA)

  53. GENEAe008-A (GENEA009 and SIVF09)

    Australia Genea (GENEA)

  54. GENEAe009-A (SIVF10 and GENEA010)

    Australia Genea (GENEA)

  55. GENEAe010-A (SIVF11 and GENEA011)

    Australia Genea (GENEA)

  56. GENEAe011-A (SIVF12 and GENEA012)

    Australia Genea (GENEA)

  57. GENEAe012-A (SIVF13 and GENEA013)

    Australia Genea (GENEA)

  58. GENEAe014-A (GENEA029)

    United States Genea (GENEA)
    Disease:

    Normal

  59. GWCMCi001-A (iPS-57)

    China Guangzhou Women and Children's Medical Center (GWCMC)
    Disease:

    Iga glomerulonephritis

  60. IBPi001-A (HPrF iPSCs 20A)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Normal

  61. ICGi022-A-1 (SOD1-G128R_K7-4L-f and SOD1-G128R)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Amyotrophic lateral sclerosis

  62. ICGi030-A (HF2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Wilson disease

  63. IMBPASi001-A (iPSC-WFS1-#1)

    Poland Institute of Medical Biology of Polish Academy of Sciences (IMBPAS)
    Disease:

    Wolfram syndrome 1

  64. INNDSUi001-A (186-Nml-F-24)

    China Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University (INNDSU)
    Disease:

    Normal

  65. KAUSTi008-F (KS4-iPSC#F)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  66. WAe001-A-F (H1X-59/H1.4-5)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  67. KLRMMEi001-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Retinitis pigmentosa

  68. KLRMMEi003-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Usher syndrome

  69. KMUGMCi006-F (TS271 #20 MT)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Tuberous sclerosis

  70. KUIMSe001-A (KhES-1)

    Japan Kyoto University (KUIMS)
    Disease:

    Normal

  71. KUIMSe002-A (KhES-2)

    Japan Kyoto University (KUIMS)

  72. KUIMSe003-A (KhES-3)

    Japan Kyoto University (KUIMS)

  73. KUIMSe003-A-1

    Japan Kyoto University (KUIMS)

  74. LCPHi001-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Obsolete_parkinson's disease

  75. LCPHi002-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson's disease

  76. LCPHi003-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson's disease

  77. MCRIi001-A-1 (PB001-OI26)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Osteogenesis imperfecta

  78. MIZMe004-A (Miz-hES9)

    South Korea MizMedi Hospital (MIZM)

  79. MIZMe005-A (Miz-hES14)

    South Korea MizMedi Hospital (MIZM)

  80. MIZMe006-A (Miz-hES15)

    South Korea MizMedi Hospital (MIZM)

  81. MIZMe007-A (Miz-hES4)

    South Korea MizMedi Hospital (MIZM)

  82. MIZMe008-A (Miz-hES5)

    South Korea MizMedi Hospital (MIZM)

  83. MIZMe009-A (Miz-hES6)

    South Korea MizMedi Hospital (MIZM)

  84. MIZMe010-A (Miz-hES7)

    South Korea MizMedi Hospital (MIZM)

  85. MIZMe011-A (Miz-hES8)

    South Korea MizMedi Hospital (MIZM)

  86. MIZMe012-A (Miz-hES10)

    South Korea MizMedi Hospital (MIZM)

  87. MIZMe013-A (Miz-hES11)

    South Korea MizMedi Hospital (MIZM)

  88. MIZMe014-A (Miz-hES12)

    South Korea MizMedi Hospital (MIZM)

  89. MIZMe015-A (Miz-hES13)

    South Korea MizMedi Hospital (MIZM)
    Disease:

    Patau syndrome

  90. MMCi002-A (MMC-iPSC-002-A)

    Taiwan Mackay Medical College (MMC)
    Disease:

    Hearing loss

  91. MUNIe001-A (CCTL 6)

    Czech Republic Masaryk University (MUNI)

  92. MUNIe001-A-1

    Czech Republic Masaryk University (MUNI)

  93. MUNIe002-A (CCTL 8)

    Czech Republic Masaryk University (MUNI)

  94. MUNIe002-A-1

    Czech Republic Masaryk University (MUNI)

  95. MUNIe003-A (CCTL 9)

    Czech Republic Masaryk University (MUNI)

  96. MUNIe003-A-1

    Czech Republic Masaryk University (MUNI)

  97. MUNIe004-A (CCTL 10)

    Czech Republic Masaryk University (MUNI)

  98. MUNIe004-A-1

    Czech Republic Masaryk University (MUNI)

  99. MUNIe005-A (CCTL 12)

    Czech Republic Masaryk University (MUNI)

  100. MUNIe005-A-1

    Czech Republic Masaryk University (MUNI)

  101. MUNIe006-A (CCTL 13)

    Czech Republic Masaryk University (MUNI)

  102. MUNIe006-A-1

    Czech Republic Masaryk University (MUNI)

  103. MUNIe007-A (CCTL 14)

    Czech Republic Masaryk University (MUNI)

  104. MUSCSDi001-A (iPSK3)

    United States Steve's Duncan Lab (MUSCSD)
    Disease:

    Normal

  105. NERCe002-A (chHES-90)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  106. NERCe002-A-1 (chHES-90-PLEX-ZsGreen)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  107. NERCe002-A-2 (chHES-90-PLEX-Luciferase)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  108. NERCe002-A-3 (chHES-90-pINDUCER20-tet-14-3-3ζ)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  109. NERCe003-A-1 (chHES-8-pINDUCER20-tet-CTNNB1)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  110. NERCe003-A-2 (chHES-8-pINDUCER10-tet-shβ-catenin)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  111. NERCe003-A-3 (chHES-8-KO-P53)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  112. NIMHi001-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Obsolete_parkinson's disease

  113. NIMHi002-A (BPPD02)

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Parkinson's disease

  114. NIMHi003-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Parkinson's disease

  115. NIMHi004-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal

  116. NIMHi005-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal

  117. NIMHi006-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal

  118. RCi002-A (FP5C-14 and RCi92)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  119. RCi002-B (FP5C-16 and RCi93)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  120. PUFHi004-A (TMEM163 c.227T>C p.(Leu76Pro) iPSC)

    China Peking University First Hospital (PUFH)
    Disease:

    Leukodystrophy

  121. PUMCi002-A (AF-iPSCs and C1)

    China Peking Union Medical College (PUMC)
    Disease:

    Normal

  122. RIi001-A (R.1.H.iPSC.1)

    Iran Royan Institute (RI)

  123. RIi002-A (BOM.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Normal

  124. RIi003-A (FHC.1.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Familial hypercholesterolemia

  125. RIi004-A (GSD.1.H.iPSC.7)

    Iran Royan Institute (RI)
    Disease:

    Glycogen storage disease

  126. RIi005-A (TYR.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Tyrosinemia type 1

  127. RIi006-A (HER.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Cholestasis

  128. RIi007-A (R.1.H.iPSC.4)

    Iran Royan Institute (RI)

  129. RIi008-A (R.1.H.iPSC.9)

    Iran Royan Institute (RI)

  130. RIi009-A (RP2.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  131. RIi010-A (LCA.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Leber congenital amaurosis

  132. RIi011-A (USH.1.H.iPSC.6)

    Iran Royan Institute (RI)
    Disease:

    Usher syndrome

  133. RIi012-A (RP.1.H.iPSC.2)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  134. RIi013-A (ARMD.1.H.iPSC.2)

    Iran Royan Institute (RI)
    Disease:

    Age-related macular degeneration

  135. RIi014-A (LHON.1.H.iPSC.5)

    Iran Royan Institute (RI)
    Disease:

    Leber congenital amaurosis

  136. RIi015-A (CNS.1.H.iPSC.10)

    Iran Royan Institute (RI)
    Disease:

    Crigler-najjar syndrome

  137. RIi016-A (CNS.2.H.iPSC.7)

    Iran Royan Institute (RI)
    Disease:

    Crigler-najjar syndrome

  138. SALKe001-A (Cyth25)

    United States The Salk Institute for Biological Studies (SALK)

  139. SCMCi001-A

    China Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine (SCMC)
    Disease:

    Normal

  140. SDPHi003-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal

  141. SDPHi004-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal

  142. SDZFYi001-A

    China Shandong Academy of Occupational Health and Occupational Medicine (SDZFY)
    Disease:

    Normal

  143. SHCDNRi001-A (IPS-51)

    China Shanghai Children's Hospital, Department of Nephrology and Rheumatology (SHCDNR)
    Disease:

    Alport syndrome

  144. SIAISi011-A (NZM)

    China Shanghai Institute for Advanced Immunochemical Studies (SIAIS) (SIAIS)
    Disease:

    Normal

  145. SKLRMi001-A

    China State Key Laboratory of Reproductive Medicine, Nanjing Medical University (SKLRM)
    Disease:

    Androgen insensitivity syndrome

  146. SNUe004-A (SNUhES4)

    South Korea Seoul National University (SNU)
    Disease:

    Normal

  147. SNUe004-A-1

    South Korea Seoul National University (SNU)
    Disease:

    Normal

  148. SNUe005-A (SNUhES11)

    South Korea Seoul National University (SNU)

  149. SNUe005-A-1

    South Korea Seoul National University (SNU)

  150. SNUe006-A (SNUhES16)

    South Korea Seoul National University (SNU)

  151. SNUe006-A-1

    South Korea Seoul National University (SNU)

  152. SSMUe003-A (SH7)

    China Shanghai Second Medical University (SSMU)

  153. SSMUe004-A (SH4)

    China Shanghai Second Medical University (SSMU)

  154. SSMUe005-A (SH28)

    China Shanghai Second Medical University (SSMU)

  155. SSMUe006-A (SH35 and SH35a)

    China Shanghai Second Medical University (SSMU)

  156. SSMUe008-A (SH38)

    China Shanghai Second Medical University (SSMU)

  157. SSMUe009-A (SH39)

    China Shanghai Second Medical University (SSMU)

  158. SSMUe010-A (SH42)

    China Shanghai Second Medical University (SSMU)

  159. SZGJMSi001-A (ZLP-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Schizophrenia

  160. SZGJMSi002-A (TSQ-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Obsessive-compulsive disorder

  161. SZGJMSi003-A (TSH-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Normal

  162. SZGJMSi004-A (WJM-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Depression

  163. TISSUi001-A (HUMIMIC101, StemUse101 and SU101)

    Germany TissUse GmbH (TISSU)
    Disease:

    Normal

  164. TUSMi001-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal

  165. TUSMi002-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal

  166. TUSMi003-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  167. TUSMi004-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsessive-compulsive disorder

  168. TUSMi005-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsolete_bipolar disorder

  169. TUSMi006-A (15M0014)

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsolete_alzheimer's disease

  170. TUSMi007-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  171. TUSMi008-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  172. UAZTi011-A (MKAZ3)

    United States University of Arizona (UAZT)
    Disease:

    Pontocerebellar hypoplasia type 1b

  173. UKHGi002-A (F-PKE (2))

    Germany Institute of Human Genetics Heidelberg (UKHG)
    Disease:

    Normal

  174. UKHGi002-B (F-PKE (3))

    Germany Institute of Human Genetics Heidelberg (UKHG)
    Disease:

    Normal

  175. ULBi002-A (Hel115.6)

    Belgium Université Libre de Bruxelles (ULB)
    Disease:

    Normal

  176. UPSFRi001-A (PB03)

    France Université Paris-Sud 11 (UPSFR)

  177. UPSFRi002-A (PB04)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  178. UPSFRi003-A (PB05-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  179. UPSFRi004-A (PB05)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  180. UPSFRi004-A-1 (PB05-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  181. UPSFRi005-A (PB06)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Down syndrome

  182. UPSFRi005-A-1 (PB06-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Down syndrome

  183. UPSFRi006-A (PB07)

    France Université Paris-Sud 11 (UPSFR)

  184. UPSFRi007-A (PB08)

    France Université Paris-Sud 11 (UPSFR)

  185. UPSFRi008-A (PB09)

    France Université Paris-Sud 11 (UPSFR)

  186. UPSFRi009-A (PB10)

    France Université Paris-Sud 11 (UPSFR)

  187. UPSFRe001-A (CL01)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Chromosomal disease

  188. UPSFRe002-A (CL02)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Monogenic disease

  189. UPSFRe003-A (CL03)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Chromosomal disease

  190. VIACe001-A (hESBGN-01 (BG01))

    United States Novocell, Inc. (VIAC)

  191. VIACe001-A-2 (BG01V)

    United States Novocell, Inc. (VIAC)
    Disease:

    Klinefelter syndrome

  192. VIACe002-A (hESBGN-02 (BG02))

    United States Novocell, Inc. (VIAC)

  193. VIACe003-A (hESBGN-03 (BG03))

    United States Novocell, Inc. (VIAC)

  194. WAe001-A (WA01 and H1)

    United States WiCell Research Institute (WA)
    Disease:

    Normal

  195. WAe007-A (H7 and WA07)

    United States WiCell Research Institute (WA)
    Disease:

    Normal

  196. WAe013-A (WA13 and H13)

    United States WiCell Research Institute (WA)

  197. WAe014-A (WA14 and H14)

    United States WiCell Research Institute (WA)

  198. WCHi001-A

    China West China Hospital (WCH)
    Disease:

    Normal

  199. WCHi003-A

    China West China Hospital (WCH)
    Disease:

    Schizophrenia

  200. WCHi004-A

    China West China Hospital (WCH)
    Disease:

    Normal

  201. WCHi005-A

    China West China Hospital (WCH)
    Disease:

    Bipolar disorder

  202. WCHi006-A

    China West China Hospital (WCH)
    Disease:

    Schizophrenia

  203. WTSIi001-A (HPSI1213i-pahc_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  204. WTSIi037-A (HPSI0114i-zoxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  205. WTSIi038-A (HPSI1113i-ieki_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  206. WTSIi046-B (HPSI0214i-wibj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  207. WTSIi047-B (HPSI0814i-bokz_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  208. WTSIi049-A (HPSI0514i-wiii_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  209. WTSIi049-B (HPSI0514i-wiii_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  210. WTSIi052-A (HPSI1114i-ziyn_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  211. WTSIi053-A (HPSI0413i-corn_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  212. WTSIi054-B (HPSI0413i-nudd_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  213. WTSIi056-A (HPSI0513i-dipe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  214. WTSIi057-B (HPSI0513i-giuf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  215. WTSIi059-A (HPSI0513i-uilw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  216. WTSIi063-A (HPSI0613i-aevs_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  217. WTSIi068-B (HPSI0613i-giuo_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  218. WTSIi069-A (HPSI0613i-hegp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  219. WTSIi073-A (HPSI0314i-sojd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  220. WTSIi082-A (HPSI1013i-cups_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  221. WTSIi083-A (HPSI1213i-xuja_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  222. WTSIi085-A (HPSI1113i-eofe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  223. WTSIi086-A (HPSI0913i-coyi_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  224. WTSIi098-A (HPSI1213i-nekd_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  225. WTSIi102-A (HPSI0413i-iakz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  226. WTSIi102-B (HPSI0413i-iakz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  227. WTSIi103-A (HPSI1213i-nusw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  228. WTSIi104-A (HPSI0513i-coio_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  229. WTSIi104-B (HPSI0513i-coio_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  230. WTSIi105-A (HPSI0313i-airc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  231. WTSIi105-B (HPSI0313i-airc_66)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  232. WTSIi106-B (HPSI0613i-hikj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  233. WTSIi109-A (HPSI0413i-coxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  234. WTSIi109-B (HPSI0413i-coxy_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  235. WTSIi110-A (HPSI0713i-darw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  236. WTSIi111-A (HPSI0513i-euir_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  237. WTSIi112-A (HPSI0613i-funp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  238. WTSIi114-A (HPSI0513i-golb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  239. WTSIi115-A (HPSI0513i-iasn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  240. WTSIi116-A (HPSI0813i-iicq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  241. WTSIi117-A (HPSI0613i-liun_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  242. WTSIi118-A (HPSI0813i-meqo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  243. WTSIi119-A (HPSI0613i-oefg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  244. WTSIi120-A (HPSI0513i-oeoo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  245. WTSIi121-A (HPSI0413i-ougl_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  246. WTSIi121-B (HPSI0413i-ougl_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  247. WTSIi122-A (HPSI0413i-peop_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  248. WTSIi123-A (HPSI0713i-qimz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  249. WTSIi124-A (HPSI0713i-ruyv_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  250. WTSIi124-B (HPSI0713i-ruyv_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  251. WTSIi125-A (HPSI0413i-uahf_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  252. WTSIi126-A (HPSI0913i-vopm_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  253. WTSIi127-A (HPSI0413i-xekf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  254. WTSIi128-A (HPSI0413i-yuze_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  255. WTSIi129-A (HPSI0613i-zisa_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  256. WTSIi130-A (HPSI0713i-aehn_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  257. WTSIi131-A (HPSI0513i-aipt_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  258. WTSIi133-A (HPSI0713i-dard_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  259. WTSIi133-B (HPSI0713i-dard_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  260. WTSIi134-B (HPSI0513i-dulv_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  261. WTSIi137-A (HPSI0613i-lizq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  262. WTSIi137-B (HPSI0613i-lizq_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  263. WTSIi138-A (HPSI0414i-mita_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  264. WTSIi139-A (HPSI1113i-oaaz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  265. WTSIi140-A (HPSI0613i-oomz_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  266. WTSIi141-A (HPSI0613i-qanu_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  267. WTSIi142-A (HPSI0613i-qony_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  268. WTSIi144-A (HPSI0114i-wegi_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  269. WTSIi145-A (HPSI0813i-wots_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  270. WTSIi146-A (HPSI0613i-xosg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  271. WTSIi168-A (HPSI0214i-poih_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  272. WTSIi168-B (HPSI0214i-poih_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  273. WTSIi169-A (HPSI0614i-miaj_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  274. WTSIi170-A (HPSI1213i-tolg_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  275. WTSIi170-B (HPSI1213i-tolg_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  276. WTSIi171-A (HPSI0914i-zerv_7)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  277. WTSIi171-B (HPSI0914i-zerv_8)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  278. WTSIi172-A (HPSI0914i-laey_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  279. WTSIi172-B (HPSI0914i-laey_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  280. WTSIi173-A (HPSI0414i-naju_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  281. WTSIi174-A (HPSI0614i-paab_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  282. WTSIi175-A (HPSI1014i-tixi_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  283. WTSIi176-B (HPSI0714i-iudw_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  284. WTSIi177-A (HPSI0414i-xojn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  285. WTSIi178-B (HPSI0215i-fawm_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  286. WTSIi179-A (HPSI0314i-wigw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  287. WTSIi180-A (HPSI0514i-puie_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  288. WTSIi180-B (HPSI0514i-puie_5)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  289. WTSIi181-A (HPSI0514i-rutc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  290. WTSIi182-A (HPSI0614i-kegd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  291. WTSIi183-A (HPSI0414i-oaqd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  292. WTSIi183-B (HPSI0414i-oaqd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  293. WTSIi184-A (HPSI1014i-qayj_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  294. WTSIi184-B (HPSI1014i-qayj_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  295. WTSIi186-A (HPSI1014i-babz_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  296. WTSIi187-A (HPSI1013i-sita_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  297. WTSIi188-A (HPSI1014i-kefb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  298. WTSIi189-A (HPSI1014i-quls_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  299. WTSIi190-A (HPSI0914i-kajh_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  300. WTSIi191-A (HPSI0215i-oilg_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  301. XWHNi001-A

    China Department of Neurology, Xuan Wu Hospital (XWHN)
    Disease:

    Alzheimer's disease

  302. XWHNi002-A

    China Department of Neurology, Xuan Wu Hospital (XWHN)
    Disease:

    Normal

  303. ZJUi010-A (ZJULLi002-A and 161103SPYLQTFSDC12)

    China Zhejiang University (ZJU)
    Disease:

    Long qt syndrome

  304. ZZUNEUi010-A (CMF001-A)

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Juvenile amyotrophic lateral sclerosis

  305. ZZUNEUi026-A

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Hypertrophic cardiomyopathy